ArticleSignal transduction and targeted therapy2023

Discovery of IHMT-337 as a potent irreversible EZH2 inhibitor targeting CDK4 transcription for malignancies.

Husheng Mei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.